Concepedia

Bradley D. Hunter

BD

Statistics

Publications

23

Citations

2.7K

H-Index

16

Active since

2009

Affiliations

Intermountain Healthcare(Current)

Massachusetts General Hospital

Brigham Young University

Dana-Farber Cancer Institute

University of Utah

Bradley D. Hunter is an author at Intermountain Healthcare specializing in medicine, oncology, and pharmacotherapy.

Publications per year

2009–2024

23

Publications

23

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia

Iván O. Rosas, Norbert Bräu, Michael R. Waters et al. · New England Journal of Medicine · 2021 · 1.1K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +13

Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity

Caron A. Jacobson, Bradley D. Hunter, Robert Redd et al. · Journal of Clinical Oncology · 2020 · 345 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study

Brandon Webb, Ithan D. Peltan, Paul N. Jensen et al. · The Lancet Rheumatology · 2020 · 310 citations · Full text

Life Sciences, Immunology, Infectious Diseases +7

CAR T-Cell Associated Neurotoxicity: Mechanisms, Clinicopathologic Correlates, and Future Directions

Bradley D. Hunter, Caron A. Jacobson · JNCI Journal of the National Cancer Institute · 2019 · 197 citations · Full text

Life Sciences, Hematology, Immunology +17

Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia

Iván O. Rosas, Norbert Bräu, Michael R. Waters et al. · medRxiv · 2020 · 132 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +11

1–5 of 23